Celestine Schnugg
Celestine “Cee Cee†Schnugg is a Silicon Valley venture capitalist and the Founding Managing Partner of Boom Capital, an early stage venture firm financing scientists and engineers.She is the first investor in Mammoth Biosciences, A-Alpha Bio, Fauna Bio, and Diligent Robotics, and early rounds of Swarm Technologies (acquired by SpaceX), Astra (NASDAQ: ASTR), Planet (NYSE: PL) Impulse Space, and Galileo Health. Prior to Boom, she was at Eric Schmidt’s Innovation Endeavors. Prior to Innovation Endeavors, she helped build the sustainability program at Apple. She has led global innovation initiatives with NASA and the White House and is the creator of Curiosity Camp and National Day of Civic Hacking. Celestine is on the Investment Committee of the Goldhirsh Foundation and was an Innovation Advisor to British Airways.Driven by the belief that no child should bear the weight of an untreatable disease, Cee Cee founded Project Atlas, a foundation accelerating translational research for cancer interception and rare pediatric conditions. Through Rare Team 6, a multidisciplinary operative, she leads efforts to uncover the biological drivers of undiagnosed conditions and build disease-specific biobanks—harnessing the decade’s most powerful technologies to cure the incurable by 2035.At Boom Capital, she not only invests inception capital but convenes a scientific society of the top 200 technologists of the 21st century.
Boom Capital
Senior Leadership AIxBioPharma Luncheon - Inflection Points: Lessons from Computing and Cloud to Catalyze AI in Bio
-
This invite-only luncheon brings together a curated group of senior leaders driving the convergence of AI and BioPharma. Hosted at SynBioBeta 2025, the event is primarily a unique opportunity to network with C-level executives, investors, and researchers shaping the future of AIxBIO. In addition to high-level networking, the luncheon will feature a panel conversation titled Inflection Points: Lessons from Computing and Cloud to Catalyze AI in Bio. Moderated by Celestine Schnugg, Founding Partner at Boom Capital, the session will explore how decades of innovation in computing and cloud infrastructure can inform the next wave of breakthroughs in biology. Joining the conversation are Sandy Pentland, a pioneer in data science and professor at MIT; Richard Socher, CEO of You.com and former Chief Scientist at Salesforce; Simon Kohl, Co-Founder and CEO of Latent Labs; and Nabiha Saklayen, Co-Founder and CEO of Cellino. Together, they will examine how lessons from past technological inflection points can be applied—and adapted—to the emerging era of AI-driven biology. https://lu.ma/a8odlz08